Posts in category Healthcare


Paratek Pharmaceuticals Inc (PTRK) Well on the Way to Broad Market Opportunity Following Successful Phase 3 for Omadacycline

Paratek Pharmaceuticals Inc (NASDAQ:PRTK) shares rose by nearly 31% after the microcap acne medicine maker …

Read more

M&A Wheels Spin for Gilead Sciences, Inc. (GILD), KOLs Pave the Way for Big Kite Pharma Inc (KITE) Axi-Cel Launch

In the biotech sphere, J.P. Morgan and Cowen are serving strong bullish forecasts for Gilead …

Read more

Direxion Shares Exchange Traded Fund Trust (JNUG): Fed Interest Rate Spikes Lead to Surprise Gains for Gold

The recent action by the Fed’s Open Market Committee to raise interest rates created what …

Read more

Steadymed (STDY) Lands Price Target Boost from H.C. Wainwright Following Big Legal Sweep for Trevyent

There were cheers from Steadymed (NASDAQ:STDY) investors last Friday following The Patent Trial and Appeal Board’s …

Read more

Aegis Analyst Cheers on Novocure Ltd (NVCR) Encouraging Clinical Data

Novocure Ltd (NASDAQ:NVCR) shares were on a close to 40% surge Monday, after the device maker announced …

Read more

Top Analyst Encouraged By Key Amgen, Inc. (AMGN) Data

Biotechnology giant Amgen, Inc. (NASDAQ:AMGN) has released positive data for its phase II study showing …

Read more

Kite Pharma Inc (KITE) Takes Compelling Step Forward Toward Securing Broad Label in Non-Hodgkin Lymphoma

Yesterday, Kite Pharma Inc (NASDAQ:KITE) impressed at the 2017 American Association of Cancer Research annual …

Read more

Acorda Therapeutics Inc (ACOR) Faces Clear Setback With Unfavorable Ampyra Ruling

On Friday, Acorda Therapeutics Inc (NASDAQ:ACOR) was met with misfortune after a district judge invalidated …

Read more

AEterna Zentaris Inc. (USA) (AEZS) Macrilen Is Back, Cheers Maxim

AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) shares are rising almost 8% today on the heels of …

Read more

Analysts Sidelined Despite Key Strides from Vertex Pharmaceuticals Incorporated (VRTX) and Regeneron Pharmaceuticals Inc (REGN)

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN) have excited investors with key clinical …

Read more